Hildebrand W - Search Results

1

Characterization of baboon class I major histocompatibility molecules. Implications for baboon-to-human xenotransplantation.

Prilliman K, Lawlor D, Ellexson M, McElwee N, Confer D, Cooper DK, Kennedy RC, Hildebrand W. Prilliman K, et al. Among authors: hildebrand w. Transplantation. 1996 Apr 15;61(7):989-96. doi: 10.1097/00007890-199604150-00001. Transplantation. 1996. PMID: 8623205

2

Description of a modified sequencing strategy and the molecular characterization of HLA-B*8201.

Ellexson M, Stewart D, Chrétien P, Zhang L, Hildebrand W. Ellexson M, et al. Among authors: hildebrand w. Tissue Antigens. 1996 May;47(5):438-41. doi: 10.1111/j.1399-0039.1996.tb02583.x. Tissue Antigens. 1996. PMID: 8795148 No abstract available.

3

Nucleotide sequence analysis of HLA-B*1523 and B*8101. Dominant alpha-helical motifs produce complex serologic recognition patterns for the HLA-B"DT" and HLA-B"NM5" antigens.

Ellexson ME, Zhang G, Stewart D, Lau M, Teresi G, Terasaki P, Roe B, Hildebrand W. Ellexson ME, et al. Among authors: hildebrand w. Hum Immunol. 1995 Oct;44(2):103-10. doi: 10.1016/0198-8859(95)00082-f. Hum Immunol. 1995. PMID: 8847228

4

Molecular characterization of HLA-A*6803.

Ellexson M, Lau M, Terasaki P, Hildebrand W. Ellexson M, et al. Among authors: hildebrand w. Immunogenetics. 1996;45(1):78-9. doi: 10.1007/s002510050172. Immunogenetics. 1996. PMID: 8881043 No abstract available.

5

Novel alleles HLA-B*7802 and B*51022: evidence for convergency in the HLA-B5 family.

Prilliman K, Steiner N, Ellexson M, Stewart D, Lau M, Terasaki P, Hurley C, Hildebrand W. Prilliman K, et al. Among authors: hildebrand w. Tissue Antigens. 1996 Jan;47(1):49-57. doi: 10.1111/j.1399-0039.1996.tb02513.x. Tissue Antigens. 1996. PMID: 8929712

6

Large-scale production of class I bound peptides: assigning a signature to HLA-B*1501.

Prilliman K, Lindsey M, Zuo Y, Jackson KW, Zhang Y, Hildebrand W. Prilliman K, et al. Among authors: hildebrand w. Immunogenetics. 1997;45(6):379-85. doi: 10.1007/s002510050219. Immunogenetics. 1997. PMID: 9089095

7

Nonhuman primate models to evaluate vaccine safety and immunogenicity.

Kennedy RC, Shearer MH, Hildebrand W. Kennedy RC, et al. Among authors: hildebrand w. Vaccine. 1997 Jun;15(8):903-8. doi: 10.1016/s0264-410x(96)00277-0. Vaccine. 1997. PMID: 9234544 Review.

8

Polymorphism at codons 114, 116, 145, and 163 muddle the typing of HLA-B*1304.

Ellexson M, Lai-Kwan P, Lau M, Muto K, Terasaki P, Cole J, Thompson C, Hildebrand W. Ellexson M, et al. Among authors: hildebrand w. Hum Immunol. 1997 Jun;55(1):66-73. doi: 10.1016/s0198-8859(97)00055-4. Hum Immunol. 1997. PMID: 9328792

9

Complexity among constituents of the HLA-B*1501 peptide motif.

Prilliman KR, Lindsey M, Jackson KW, Cole J, Bonner R, Hildebrand WH. Prilliman KR, et al. Among authors: hildebrand wh. Immunogenetics. 1998 Jul;48(2):89-97. doi: 10.1007/s002510050408. Immunogenetics. 1998. PMID: 9634472

10

Characterization of an HLA-A26 serologic variant.

Ellexson ME, Peck RL, Stewart D, Keller J, Hildebrand WH. Ellexson ME, et al. Among authors: hildebrand wh. Immunogenetics. 1998 Jul;48(2):152-5. doi: 10.1007/s002510050417. Immunogenetics. 1998. PMID: 9634481 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

195 results

Search Page

Filters